| Histological diagnosis | No adjuvant RT | Postoperative RT | P-value |
| A + AB | 21 | 2 | 0.034 |
| B | 20 | 10 | |
| Histological diagnosis | No relapse | Relapses | P-value |
| A + AB | 23 | 0 | 0.069 |
| B | 26 | 4 | |
| Masaoka | No adjuvant RT | Adjuvant RT | P-value |
| I | 18 | 0 | 0.006 |
| II | 21 | 9 | |
| III | 2 | 3 | |
| Masaoka | No relapse | Relapse | P-value |
| I | 18 | 0 | 0.011 |
| II | 28 | 2 | |
| III | 3 | 2 |
| Histological diagnosis | No adjuvant RT | Postoperative RT | P-value |
| A + AB | 21 | 2 | 0.034 |
| B | 20 | 10 | |
| Histological diagnosis | No relapse | Relapses | P-value |
| A + AB | 23 | 0 | 0.069 |
| B | 26 | 4 | |
| Masaoka | No adjuvant RT | Adjuvant RT | P-value |
| I | 18 | 0 | 0.006 |
| II | 21 | 9 | |
| III | 2 | 3 | |
| Masaoka | No relapse | Relapse | P-value |
| I | 18 | 0 | 0.011 |
| II | 28 | 2 | |
| III | 3 | 2 |
RT: radiotherapy.
| Histological diagnosis | No adjuvant RT | Postoperative RT | P-value |
| A + AB | 21 | 2 | 0.034 |
| B | 20 | 10 | |
| Histological diagnosis | No relapse | Relapses | P-value |
| A + AB | 23 | 0 | 0.069 |
| B | 26 | 4 | |
| Masaoka | No adjuvant RT | Adjuvant RT | P-value |
| I | 18 | 0 | 0.006 |
| II | 21 | 9 | |
| III | 2 | 3 | |
| Masaoka | No relapse | Relapse | P-value |
| I | 18 | 0 | 0.011 |
| II | 28 | 2 | |
| III | 3 | 2 |
| Histological diagnosis | No adjuvant RT | Postoperative RT | P-value |
| A + AB | 21 | 2 | 0.034 |
| B | 20 | 10 | |
| Histological diagnosis | No relapse | Relapses | P-value |
| A + AB | 23 | 0 | 0.069 |
| B | 26 | 4 | |
| Masaoka | No adjuvant RT | Adjuvant RT | P-value |
| I | 18 | 0 | 0.006 |
| II | 21 | 9 | |
| III | 2 | 3 | |
| Masaoka | No relapse | Relapse | P-value |
| I | 18 | 0 | 0.011 |
| II | 28 | 2 | |
| III | 3 | 2 |
RT: radiotherapy.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
